The DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.
Plasma Norepinephrine as a Guide to Prognosis in Patients with Chronic Congestive Heart Failure
Abstract
Hemodynamics, plasma norepinephrine, and plasma renin activity were measured at supine rest in 106 patients (83 men and 23 women) with moderate to severe congestive heart failure. During follow-up lasting 1 to 62 months, 60 patients died (57 per cent); 47 per cent of the deaths were sudden, and 45 per cent were related to progressive heart failure. Statistically unrelated to the risk of mortality were cause of disease (60 patients had coronary disease, and 46 had cardiomyopathy), age (mean, 54.8 years), cardiac index (mean, 2.11 liters per minute per square meter of body-surface area), pulmonary wedge pressure (mean, 24.5 mm Hg), and mean arterial pressure (mean, 83.2 mm Hg). A multivariate analysis of the five significant univariate prognosticators--heart rate (mean, 84.4 beats per minute), plasma renin activity (mean, 15.4 ng per milliliter per hour), plasma norepinephrine (mean, 700 pg per milliliter), serum sodium (mean, 135.7 mmol per liter), and stroke-work index (mean, 21.0 g-meters per square meter)--found only plasma norepinephrine to be independently (P = 0.002) related to the subsequent risk of mortality. Norepinephrine was also higher in patients who died from progressive heart failure than in those who died suddenly. These data suggest that a single resting venous blood sample showing the plasma norepinephrine concentration provides a better guide to prognosis than other commonly measured indexes of cardiac performance.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“A prime example is provided by cardiac failure, where the level of elevation of the plasma concentration of norepinephrine in plasma predicts reduced longevity.18”
From Obesity Paradox in Hypertension: Is This Because Sympathetic Activation in Obesity-Hypertension Takes a Benign Form? (2018) · cites this paper as [18]
In the citing paper
“Ongoing systemic sympathetic activation has long been thought to be noxious, in heart failure 18,19 and renal failure.113”
From Obesity Paradox in Hypertension: Is This Because Sympathetic Activation in Obesity-Hypertension Takes a Benign Form? (2018) · cites this paper as [18]
Citations
Cites
Nonparametric Estimation from Incomplete Observations
Kaplan, E. L., & Meier, P. (1958) · Journal of the American Statistical Association · doi:10.1080/01621459.1958.10501452 · Cited by 39,158
Fundamentals of Biostatistics.
(1969) · Annals of Internal Medicine · doi:10.7326/0003-4819-70-4-873 · Cited by 4,573
A Generalized Wilcoxon Test for Comparing Arbitrarily Singly-Censored Samples
Gehan, E. A. (1965) · Biometrika · doi:10.1093/biomet/52.1-2.203 · Cited by 3,407
Plasma norepinephrine in congestive heart failure
Thomas, J. A., & Marks, B. H. (1978) · The American Journal of Cardiology · doi:10.1016/0002-9149(78)90162-5 · Cited by 925
A simplified radiometric assay for plasma norepinephrine and epinephrine
Passon, P. G., & Peuler, J. D. (1973) · Analytical Biochemistry · doi:10.1016/0003-2697(73)90517-4 · Cited by 637
Levine, T. B., Francis, G. S., Goldsmith, S. R., Simon, A. B., & Cohn, J. N. (1982) · The American Journal of Cardiology · doi:10.1016/0002-9149(82)90243-0 · Cited by 614
Self-citationUse of plasma norepinephrine for evaluation of sympathetic neuronal function in man
Lake, C., Ziegler, M. G., & Kopin, I. J. (1976) · Life Sciences · doi:10.1016/0024-3205(76)90210-1 · Cited by 548
Determinants of Survival in Patients with Ventricular Tachyarrhythmias
Swerdlow, C. D., Winkle, R. A., & Mason, J. W. (1983) · New England Journal of Medicine · doi:10.1056/nejm198306163082402 · Cited by 508
Comparative assessment of stimuli that release neuronal and adrenomedullary catecholamines in man.
Robertson, D., Johnson, G., Robertson, R. M., Nies, A. S., Shand, D. G., & Oates, J. A. (1979) · Circulation · doi:10.1161/01.cir.59.4.637 · Cited by 467
Chidsey, C. A., Harrison, D. C., & D, E. B. M. (1962) · New England Journal of Medicine · doi:10.1056/nejm196209272671305 · Cited by 439
Research works printed but not linked: 2
- Hopkins A. Survival analysis with covariates — Cox models. In: BMDP statistical software. Berkeley, Calif.: University of California Press, 1983: 576–94.
- 10.2307/2281868 · DOI · Paper page
Cited by
Sorted by citations
Items 901–1,000 of 1,002
New Perspectives in Magnesium Research
Nishizawà, Y., Morii, H., & Durlach, J. (2007) · Springer eBooks · doi:10.1007/978-1-84628-483-0 · Cited by 69
Cardona‐Guarache, R., Padala, S. K., Velazco‐Davila, L., Cassano, A. D., Abbate, A., Ellenbogen, K. A., & Koneru, J. N. (2017) · Journal of Cardiovascular Electrophysiology · doi:10.1111/jce.13249 · Cited by 49
Higher Sympathetic Nerve Activity During Ventricular (VVI) Than During Dual-Chamber (DDD) Pacing
Taylor, J. A., Morillo, C. A., Eckberg, D. L., & Ellenbogen, K. A. (1996) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(96)00389-0 · Cited by 49
Reflex cardiovascular control in congestive heart failure
Mancia, G., Seravalle, G., Giannattasio, C., Bossi, M., Preti, L., Cattaneo, B. M., & Grassi, G. M. (1992) · The American Journal of Cardiology · doi:10.1016/0002-9149(92)91251-x · Cited by 49
PEHRSSON, S. K., Hjemdahl, P., Nordlander, R., & Åström, H. (1988) · Heart · doi:10.1136/hrt.60.3.212 · Cited by 49
Stern, J. E. (2014) · Journal of Neuroendocrinology · doi:10.1111/jne.12252 · Cited by 48
Longitudinal Cognitive Performance in Older Adults With Cardiovascular Disease
Stanek, K. M., Gunstad, J., Paul, R. H., Poppas, A., Jefferson, A. L., Sweet, L. H., Hoth, K. F., Haley, A. P., Forman, D. E., & Cohen, R. A. (2009) · The Journal of Cardiovascular Nursing · doi:10.1097/jcn.0b013e31819b54de · Cited by 48
Papademetriou, V., Rashidi, A., Tsioufis, C., & Doumas, M. (2014) · Circulation · doi:10.1161/circulationaha.113.005405 · Cited by 55
Shi, Z., Chen, A., Xu, Y., Chen, Q., Gao, X.-Y., Wang, W., & Zhu, G. (2009) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-008-0627-x · Cited by 48
The cardiovascular implications of hypokalemia
Coca, S. G., Perazella, M. A., & Buller, G. K. (2005) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2004.10.015 · Cited by 48
Glick, D. B. (2010) · Elsevier eBooks · doi:10.1016/b978-0-443-06959-8.00012-1 · Cited by 48
Long-term chronic baroreflex activation
Gronda, E., Seravalle, G., Trevano, F. Q., Costantino, G., Casini, A., Alsheraei, A., Lovett, E. G., Vanoli, E., Mancia, G., & Grassi, G. M. (2015) · Journal of Hypertension · doi:10.1097/hjh.0000000000000603 · Cited by 48
Piccirillo, G., Quaglione, R., Nocco, M., Naso, C., Moisè, A., Lionetti, M., Carlo, S. D., & Marigliano, V. (2002) · The American Journal of Cardiology · doi:10.1016/s0002-9149(02)02778-9 · Cited by 48
Sympathetic control after cardiac resynchronization therapy: responders versus nonresponders
Najem, B., Unger, P., Preumont, N., Jansens, J.-L., Houssière, A., Pathak, A., Xhaët, O., Gabriël, L., Friart, A., Roy, L. D., et al. (2006) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00373.2006 · Cited by 48
Cardiac-specific sympathetic activation in men and women with and without heart failure
Mitoff, P. R., Gam, D., Ivanov, J., Al‐Hesayen, A., Azevedo, E. R., Newton, G. E., Parker, J. D., & Mak, S. S. (2010) · Heart · doi:10.1136/hrt.2010.199760 · Cited by 50
The role of exercise testing in chronic heart failure.
Lipkin, D. P. (1987) · Heart · doi:10.1136/hrt.58.6.559 · Cited by 48
Zhang, L., Wang, Z., & Nattel, S. (2002) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.01138.2000 · Cited by 48
TNF-α enhances cardiac myocyte NO production through MAP kinase-mediated NF-κB activation
Kan, H. J., Xie, Z., & Finkel, M. S. (1999) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.1999.277.4.h1641 · Cited by 48
Subnormal parasympathetic activity after cardiac transplantation
Smith, M. L., Ellenbogen, K. A., Eckberg, D. L., Sheehan, H. M., & Thames, M. D. (1990) · The American Journal of Cardiology · doi:10.1016/0002-9149(90)91108-i · Cited by 48
Heart Rate Variability in Heart Failure
Moore, R., & Nolan, J. (2004) · doi:10.1002/9780470987483.ch13 · Cited by 48
Sodium and Water Excretion Abnormalities in Congestive Heart Failure
Mettauer, B., Rouleau, J. L., Bichet, D. G., JUNEAU, C., KORTAS, C., BARJON, J.-N., & de Champlain, J. (1986) · Annals of Internal Medicine · doi:10.7326/0003-4819-105-2-161 · Cited by 47
Yoshihisa, A., Suzuki, S., Miyata, M., Yamaki, T., Sugimoto, K., Kunii, H., Nakazato, K., Suzuki, H., Saitoh, S., & Takeishi, Y. (2012) · Circulation Journal · doi:10.1253/circj.cj-12-0453 · Cited by 47
Grassi, G. M., Seravalle, G., Quarti‐Trevano, F., Mineo, C., Lonati, L. M., Facchetti, R., & Mancia, G. (2010) · Journal of Hypertension · doi:10.1097/hjh.0b013e328337a9fd · Cited by 46
Plasma endothelin in congestive heart failure: A predictor of cardiac death?
Galatius, S., Wroblewski, H., Emmeluth, C., Bie, P., Haunsø, S., & Kastrup, J. (1996) · Journal of Cardiac Failure · doi:10.1016/s1071-9164(96)80025-x · Cited by 47
Pliquett, R. U., Cornish, K. G., Patel, K. P., Schultz, H. D., Peuler, J. D., & Zucker, I. H. (2003) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00486.2003 · Cited by 47
Schultz-Hector, S., Böhm, M., Blöchel, A., Dominiak, P., Erdmann, E., Müller-Schauenburg, W., & Weber, A. (1992) · PubMed · Cited by 47
Ware, W. A., Lund, D. D., Subieta, A. R., & Schmid, P. G. (1990) · Journal of the American Veterinary Medical Association · doi:10.2460/javma.1990.197.11.1475 · Cited by 47
Revisiting salt and water retention: new diuretics, aquaretics, and natriuretics
Costello‐Boerrigter, L. C., Boerrigter, G., & Burnett, J. C. J. (2003) · Medical Clinics of North America · doi:10.1016/s0025-7125(02)00181-5 · Cited by 47
Teboul, J., Graïni, L., Boujdaria, R., Berton, C., & Richard, C. (1993) · CHEST Journal · doi:10.1378/chest.103.1.81 · Cited by 47
Beta blocker treatment in heart failure
Carson, P. E. (1999) · Progress in Cardiovascular Diseases · doi:10.1053/pcad.1999.0410301 · Cited by 47
Transgenic models of α2-adrenergic receptor subtype function
Hein, L. (2008) · Springer eBooks · doi:10.1007/bfb0117493 · Cited by 47
Katoh, S., Shishido, T., Kutsuzawa, D., Arimoto, T., Netsu, S., Funayama, A., Ishino, M., Niizeki, T., Nishiyama, S., Takahashi, H., et al. (2010) · Annals of Nuclear Medicine · doi:10.1007/s12149-010-0409-3 · Cited by 45
Wang, H., Zhang, F., Zhang, Y., Gao, X.-Y., Wang, W., & Zhu, G. (2005) · Autonomic Neuroscience · doi:10.1016/j.autneu.2005.07.003 · Cited by 46
Groehs, R. V., Toschi‐Dias, E., Antunes‐Correa, L. M., Trevizan, P. F., Rondon, M. U. P. B., de Oliveira, P., Alves, M. J. N. N., Almeida, D. R., Middlekauff, H. R., & Negrão, C. E. (2015) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00723.2014 · Cited by 46
Renal Denervation Improves Exaggerated Sympathoexcitation in Rats With Heart Failure
Patel, K. P., Xu, B., Liu, X., Sharma, N. M., & Zheng, H. (2016) · Hypertension · doi:10.1161/hypertensionaha.115.06794 · Cited by 46
Sharma, N. M., & Patel, K. P. (2016) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2017.1265505 · Cited by 46
Murai, H., Takamura, M., Maruyama, M., Nakano, M., Ikeda, T., Kobayashi, D., Otowa, K., Ootsuji, H., Okajima, M., Furusho, H., et al. (2009) · The Journal of Physiology · doi:10.1113/jphysiol.2009.172627 · Cited by 46
Tsukamoto, T., Morita, K., Naya, M., Inubushi, M., Katoh, C., Nishijima, K., Kuge, Y., Okamoto, H., Tsutsui, H., & Tamaki, N. (2007) · Journal of Nuclear Medicine · doi:10.2967/jnumed.107.043794 · Cited by 46
Nightingale, A. K., Blackman, D. J., Field, R., GLOVER, N. J., Pegge, N. C., Mumford, C. E., Schmitt, M., ELLIS, G. R., Morris‐Thurgood, J., & Frenneaux, M. P. (2003) · Clinical Science · doi:10.1042/cs20020334 · Cited by 46
Han, Y., Shi, Z., Zhang, F., Yang, Y., Zhong, M., Gao, X., Wang, W., & Zhu, G. (2007) · European Journal of Heart Failure · doi:10.1016/j.ejheart.2007.07.004 · Cited by 46
Calcium signaling phenomena in heart diseases: a perspective
Chakraborti, S., Das, S. K., Kar, P., Ghosh, B., Samanta, K., Kolley, S., Ghosh, S., Roy, S., & Chakraborti, T. (2006) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-006-9355-8 · Cited by 46
Oginö, K., Ogura, K., Kinugasa, Y., Furuse, Y., Uchida, K. S. K., Shimoyama, M., Kinugawa, T., Osaki, S., Kato, M., Tomikura, Y., et al. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-020314 · Cited by 46
de Milliano, P. A. R., de Groot, A. C., Tijssen, J. G. P., van Eck‐Smit, B. L. F., van Zwieten, P. A., & Lie, K. I. (2002) · American Heart Journal · doi:10.1067/mhj.2002.121807 · Cited by 46
Wang, J., Meissner, A., Malek, S., Chen, Y., Ke, Q., Zhang, J., Chu, V., Hampton, T., Crumpacker, C. S., Abelmann, W. H., et al. (2005) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00258.2005 · Cited by 46
Neuroendocrine activity in congestive heart failure
Francis, G. S. (1990) · The American Journal of Cardiology · doi:10.1016/0002-9149(90)90474-f · Cited by 46
Self-citationFactors influencing survival and mode of death in severe chronic ischaemic cardiac failure.
Glover, D. R., & Littler, W. A. (1987) · Heart · doi:10.1136/hrt.57.2.125 · Cited by 45
Patel, H. C., Rosen, S. D., Lindsay, A. C., Hayward, C., Lyon, A. R., & Mario, C. D. (2013) · International Journal of Cardiology · doi:10.1016/j.ijcard.2013.10.058 · Cited by 45
Future G protein-coupled receptor targets for treatment of heart failure
Rengo, G., Lymperopoulos, A., & Koch, W. J. (2009) · Current Treatment Options in Cardiovascular Medicine · doi:10.1007/s11936-009-0033-5 · Cited by 44
Wray, D. W., & Supiano, M. A. (2010) · Hypertension · doi:10.1161/hypertensionaha.109.147058 · Cited by 45
Sympathetic Activation in Congestive Heart Failure: Reproducibility of Neuroadrenergic Markers
Grassi, G. M., Bolla, G. B., Quarti‐Trevano, F., Arenare, F., Brambilla, G., & Mancia, G. (2008) · European Journal of Heart Failure · doi:10.1016/j.ejheart.2008.09.013 · Cited by 44
Ma, L., Cui, B., Shao, Y., Ni, B., Zhang, W., Luo, Y., & Zhang, S. (2014) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00889.2013 · Cited by 45
Interaction between cardiac sympathetic drive and heart rate in heart failure
Kaye, D. M., Smirk, B., Finch, S., Williams, C., & Esler, M. (2004) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2004.07.058 · Cited by 45
β-Adrenergic Activation Initiates Chamber Dilatation in Concentric Hypertrophy
Badenhorst, D., Veliotes, D. G. A., Maseko, M. J., Tsotetsi, O. J., Brooksbank, R. L., Naidoo, A., Woodiwiss, A. J., & Norton, G. R. (2003) · Hypertension · doi:10.1161/01.hyp.0000056601.29613.dd · Cited by 46
Quilliot, D., Fluckiger, L., Zannad, F. M., Drouin, P., & Ziegler, O. (2001) · Clinical Autonomic Research · doi:10.1007/bf02322050 · Cited by 48
Reversing Advanced Heart Failure by Targeting Ca2+Cycling
Kaye, D. M., Hoshijima, M., & Chien, K. R. (2008) · Annual Review of Medicine · doi:10.1146/annurev.med.59.052407.103237 · Cited by 46
Wang, Y., Liu, X.-F., Cornish, K. G., Zucker, I. H., & Patel, K. P. (2004) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00497.2004 · Cited by 45
Scalvini, S., Volterrani, M., Zanelli, E., Pagani, M., MAZZUERO, G., Coats, A. J. S., & Giordano, A. (1998) · International Journal of Cardiology · doi:10.1016/s0167-5273(98)00252-6 · Cited by 45
Fundamental considerations of β-adrenoceptor subtypes in human heart failure
Molenaar, P., & Parsonage, W. A. (2005) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2005.05.005 · Cited by 46
Recent Advances in the Understanding of Water Metabolism in Heart Failure
Schrier, R. W., & Martin, P.-Y. (1998) · Advances in experimental medicine and biology · doi:10.1007/978-1-4615-4871-3_53 · Cited by 45
Predictors of Mortality in Patients with Heart Failure
Gradman, A. H., & DEEDWANIA, P. C. (1994) · Cardiology Clinics · doi:10.1016/s0733-8651(18)30123-1 · Cited by 44
The “Unsympathetic” Nervous System of Heart Failure
Floras, J. S. (2002) · Circulation · doi:10.1161/01.cir.0000013788.71817.16 · Cited by 45
Modifications of skeletal muscle ryanodine receptor type 1 and exercise intolerance in heart failure
Rullman, E., Andersson, D. C., Melin, M., Reiken, S. R., MANCINI, D. M., Marks, A. R., Lund, L. H., & Gustafsson, T. P. (2013) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2013.06.026 · Cited by 44
Atrial Fibrillation in Congestive Heart Failure
Seiler, J., & Stevenson, W. G. (2009) · Cardiology in Review · doi:10.1097/crd.0b013e3181c21cff · Cited by 44
Cardiac Resynchronization Therapy Upregulates Cardiac Autonomic Control
Cha, Y., Oh, J. K., Miyazaki, C., Hayes, D. L., Rea, R. F., Shen, W.-K., Asirvatham, S. J., KEMP, B. J., Hodge, D. O., Chen, P., et al. (2008) · Journal of Cardiovascular Electrophysiology · doi:10.1111/j.1540-8167.2008.01190.x · Cited by 43
Novel iodinated tracers, MIBG and BMIPP, for nuclear cardiology
Tamaki, N., & Yoshinaga, K. (2010) · Journal of Nuclear Cardiology · doi:10.1007/s12350-010-9305-4 · Cited by 43
Cardiovascular Problems on Hemodialysis
Ritz, E., & Bommer, J. (2009) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.01960309 · Cited by 44
Recent Advances and Clinical Applications of PET Cardiac Autonomic Nervous System Imaging
Boutagy, N. E., & Sinusas, A. J. (2017) · Current Cardiology Reports · doi:10.1007/s11886-017-0843-0 · Cited by 44
Ryanodine Receptor Calcium Leak in Circulating B-Lymphocytes as a Biomarker in Heart Failure
Kushnir, A., Santulli, G., Reiken, S. R., Coromilas, E. J., Godfrey, S., Brunjes, D. L., Colombo, P. C., yuzefpolskaya, M., Sokol, S. I., Kitsis, R. N., et al. (2018) · Circulation · doi:10.1161/circulationaha.117.032703 · Cited by 45
Surinkaew, S., Aflaki, M., Takawale, A. R., Chen, Y., Qi, X., Gillis, M., Shi, Y., Tardif, J., Chattipakorn, N., & Nattel, S. (2018) · Cardiovascular Research · doi:10.1093/cvr/cvy173 · Cited by 43
Diastolic Ventricular Interaction
Atherton, J. J., Thomson, H. L., Moore, T. D., Wright, K. N., Muehle, G. W. F., Fitzpatrick, L. E., & Frenneaux, M. P. (1997) · Circulation · doi:10.1161/01.cir.96.12.4273 · Cited by 44
Yamakawa, H., Takeuchi, M., Takaoka, H., Hata, K., Mori, M., & Yokoyama, M. (1996) · Circulation · doi:10.1161/01.cir.94.3.340 · Cited by 44
Benefits of β-Blocker Therapy for Heart Failure
Goldstein, S. (2002) · Archives of Internal Medicine · doi:10.1001/archinte.162.6.641 · Cited by 42
Huang, P. H., Leu, H.-B., Chen, J. W., Wu, T., Lu, T.-M., Ding, Y., & Lin, S. J. (2005) · Heart · doi:10.1136/hrt.2005.064147 · Cited by 44
Yoga in Heart Failure Patients: A Pilot Study
Howie‐Esquivel, J., Lee, J., Collier, G., Mehling, W. E., & Fleischmann, K. E. (2010) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2010.04.011 · Cited by 47
Zheng, M., Han, Q., & Xiao, R. (2004) · PubMed · Cited by 44
Pathophysiology of water and sodium retention: edematous states with normal kidney function
Bekheirnia, M. R., & Schrier, R. W. (2006) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2005.09.008 · Cited by 44
Adamson, P. B., & Vanoli, E. (2001) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(01)01185-8 · Cited by 44
Cardiac Physiology of Aging: Extracellular Considerations
Horn, M. (2015) · Comprehensive physiology · doi:10.1002/cphy.c140063 · Cited by 46
Autonomic control of ventricular function in health and disease: current state of the art
van Weperen, V. Y. H., Ripplinger, C. M., & Vaseghi, M. (2023) · Clinical Autonomic Research · doi:10.1007/s10286-023-00948-8 · Cited by 44
Huang, P., Leu, H., Chen, J., & Lin, S. (2005) · Preventive Cardiology · doi:10.1111/j.1520-037x.2005.3847.x · Cited by 46
Li, Y., Zhang, T., Na-Dan, Z., Li‐Sha, G., Qin, L., Guan, X., & Lin, J. (2012) · PLoS ONE · doi:10.1371/journal.pone.0039394 · Cited by 43
Current and future G protein-coupled receptor signaling targets for heart failure therapy
Lymperopoulos, A., Siryk, A., & Dabul, S. (2013) · Drug Design Development and Therapy · doi:10.2147/dddt.s35905 · Cited by 44
Tan, L., Burniston, J. G., Clark, W. A., Ng, Y., & Goldspink, D. F. (2003) · Journal of Cardiovascular Pharmacology · doi:10.1097/00005344-200304000-00003 · Cited by 43
Hamdani, N., Borbély, A., Veenstra, S., Kooij, V., Vrydag, W., Zaremba, R., dos Remedios, C. G., Niessen, H. W. M., Michel, M. C., Paulus, W. J., et al. (2010) · Journal of Muscle Research and Cell Motility · doi:10.1007/s10974-010-9231-8 · Cited by 43
Gerson, M. C., McGuire, N., & Wagoner, L. E. (2003) · Journal of Cardiac Failure · doi:10.1054/s1071-9164(03)00134-9 · Cited by 43
The myocardial matrix and the development and progression of ventricular remodeling
Sackner‐Bernstein, J. (2000) · Current Cardiology Reports · doi:10.1007/s11886-000-0007-4 · Cited by 43
Seasonal congestive heart failure mortality and hospitalisation trends, Quebec 1990–1998: Figure 1
Feldman, D. E., Platt, R. W., Déry, V., Kapetanakis, C., Lamontagne, D., Ducharme, A., Giannetti, N., Frenette, M., & Beck, E. J. (2004) · Journal of Epidemiology & Community Health · doi:10.1136/jech.58.2.129 · Cited by 43
Gilsbach, R., Brede, M., Beetz, N., Moura, E., Muthig, V., Gerstner, C., Barreto, F., Neubauer, S., Vieira‐Coelho, M. A., & Hein, L. (2007) · Cardiovascular Research · doi:10.1016/j.cardiores.2007.05.017 · Cited by 43
Chronic heart failure and exercise
Kokkinos, P. F., Choucair, W. K., Graves, P. R. T., Papademetriou, V., & Ellahham, S. (2000) · American Heart Journal · doi:10.1067/mhj.2000.106916 · Cited by 43
Sustained Sympathoinhibitory Effects of Cardiac Resynchronization Therapy in Severe Heart Failure
Grassi, G. M., Vincenti, A., Brambilla, R., Trevano, F. Q., Dell’Oro, R., Cirò, A., Trocino, G., Vincenzi, A., & Mancia, G. (2004) · Hypertension · doi:10.1161/01.hyp.0000144271.59333.a7 · Cited by 43
Central and peripheral components of cardiac failure
MANCINI, D. M., Jemtel, T. H. L., Factor, S. M., & Sonnenblick, E. H. (1986) · The American Journal of Medicine · doi:10.1016/0002-9343(86)90138-5 · Cited by 42
Fajardo, G., Zhao, M., Powers, J. C., & Bernstein, D. (2006) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2005.12.004 · Cited by 42
Eriksson, S. V., Eneroth, P. H. E., KJEKSHUS, J. K., Offstad, J., & Swedberg, K. B. (1994) · Clinical Cardiology · doi:10.1002/clc.4960171107 · Cited by 42
Tsutamoto, T., Sakai, H., 伊部, 邦., Yamaji, M., Kawahara, C., Nakae, I., Fujii, M., Yamamoto, T., & Horie, M. (2011) · Circulation Journal · doi:10.1253/circj.cj-11-0222 · Cited by 42
Removal of the Cardiac Troponin I N-terminal Extension Improves Cardiac Function in Aged Mice
Biesiadecki, B. J., Tachampa, K., Yuan, C., Jin, J., de Tombe, P. P., & Solaro, R. J. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.086892 · Cited by 42
Park, J. J., Choi, D., Yoon, C., Oh, I., Jeon, E., Kim, J., Cho, M., Chae, S. C., Ryu, K.-H., Yoo, B., et al. (2013) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2013.10.022 · Cited by 42
Mori, Y. (2002) · Trends in Cardiovascular Medicine · doi:10.1016/s1050-1738(02)00173-1 · Cited by 42
Autonomic regulation of the immune system in cardiovascular diseases
Abboud, F. M., & Singh, M. V. (2017) · AJP Advances in Physiology Education · doi:10.1152/advan.00061.2017 · Cited by 43
Nauman, J., Nilsen, T. I. L., Wisløff, U., & Vatten, L. J. (2010) · Journal of Epidemiology and Community Health · doi:10.1136/jech.2009.093088 · Cited by 41
Metadata
- Authors
- Cohn, J. N., Levine, T. B., Olivari, M. T., Garberg, V., Lura, D., Francis, G. S., Simon, A. B., & Rector, T.
- Affiliations
- University of Minnesota (US)
- ORCID
- Cohn, Jay N.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 1984-09-27
- Volume
- 311
- Issue
- 13
- Pages
- 819-823
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2338638760
- Cited by
- 3,125
- References
- 23
- Citations by year
- 2026: 22 · 2025: 30 · 2024: 22 · 2023: 44 · 2022: 50 · 2021: 49 · 2020: 54 · 2019: 58 · 2018: 42 · 2017: 57 · 2016: 75 · 2015: 73 · 2014: 101 · 2013: 87 · 2012: 88
- FWCI
- 34.36
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Heart Failure Treatment and Management
- Health Sciences › Medicine › Nephrology › Electrolyte and hormonal disorders
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Fibrosis and Remodeling
- Keywords
- plasma norepinephrine, congestive heart failure, prognosis, mortality risk, plasma renin activity, hemodynamics, sudden death, progressive heart failure, prognostic factors, heart rate, stroke work index, serum sodium
- MeSH terms
- Age Factors, Blood Pressure, Female, Follow-Up Studies, Heart Failure, Heart Rate, Hemodynamics, Humans, Male, Middle Aged, Norepinephrine, Prognosis, Pulmonary Wedge Pressure, Renin
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review